People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| AcuFocus, Inc. | — | Biotechnology | Series C | $167.7M | $981.9M | 2016 |
| CardioFocus, Inc. | — | Biotechnology | Series B | $153.2M | $351.9M | 2010 |
| Torax Medical Inc | — | Biotechnology | Series B | $77.0M | $992.3M | 2013 |
| Femasys Inc | — | Biotechnology | Series B | $74.7M | $32.0M | 2016 |
| Sebacia, Inc. | — | Other Health Care | Series B | $71.2M | $221.5M | 2010 |
| Sadra Medical, Inc. | — | Other Health Care | Series B | $23.0M | $88.6M | 2009 |
| Cellutions Inc | — | Biotechnology | Pre-Seed | $1.0M | $55.2M | 2009 |
Charles Larsen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Charles Larsen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Garvey | 3 | 6 |
| Anthony Lando | 2 | 6 |
| Steven Waite | 2 | 4 |
| Thomas Weldon | 2 | 3 |
| Gordon Wyatt | 2 | 2 |
| FARHAD KHOSRAVI | 1 | 14 |
| PAUL LAVIOLETTE | 1 | 12 |
| William J. Link | 1 | 10 |
| Joshua Silverman | 1 | 8 |
| Buzz Benson | 1 | 8 |
| James Thomas | 1 | 8 |
| David Milne | 1 | 7 |
| John Deedrick | 1 | 7 |
| Ryan Schwarz | 1 | 7 |
| Bruce Robertson | 1 | 7 |
| John Adams | 1 | 6 |
| Peter McNerney | 1 | 6 |
| Parker H. Petit | 1 | 5 |
| Jeffrey Lightcap | 1 | 5 |
| Robert E. Grant | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.